The talk on the town.

Berkeley-based startup, Kintsugi, is closing mental healthcare gaps across health organizations by augmenting clinicians with AI to identify, triage, and care for patients at scale.

Kintsugi raises $20M to scale up voice biomarker-based mental health tech. Led by Insight Partners with participation from Acrew Capital, Darling Ventures, Citta Capital, Side Door Ventures, Primetime Partners, IT Farm, AngelList Fund and Alpha Edison.

Kintsugi is using machine learning to identify signs of depression and anxiety from biomarkers in patients’ voices and has raised a $20 million Series A round led by Insight Partners. The company has raised $28 million to date.

Mental health vocal biomarker startup has raised $20 million in a Series A funding round led by Insight Partners. The new investment will go toward scaling Kintsugi and improving its voice test for detecting subtle signs of anxiety, depression, and other potential mental health issues.

Kintsugi, a startup that aims to identify signs of depression and anxiety using vocal biomarkers, scored $20 million in Series A funding. The latest round comes about six months after the company announced it had raised $8 million in seed funding.